Pages that link to "Q54119583"
Jump to navigation
Jump to search
The following pages link to Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner. (Q54119583):
Displaying 4 items.
- Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review (Q58755253) (← links)
- RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals (Q64082340) (← links)
- Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma (Q90012544) (← links)
- Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion (Q90499083) (← links)